Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2 …
…, M Koutsoukos, MA Kimmel, R Masotti… - The Lancet Infectious …, 2021 - thelancet.com
Background CoV2 preS dTM is a stabilised pre-fusion spike protein vaccine produced in a
baculovirus expression system being developed against SARS-CoV-2. We present interim …
baculovirus expression system being developed against SARS-CoV-2. We present interim …
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2 …
…, M Koutsoukos, D Lopez, R Masotti… - The Lancet Infectious …, 2022 - thelancet.com
Background We evaluated our SARS-CoV-2 prefusion spike recombinant protein vaccine (CoV2
preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two-…
preS dTM) with different adjuvants, unadjuvanted, and in a one-injection and two-…
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines …
Background In a parallel-group, international, phase 3 study (ClinicalTrials.gov NCT04762680),
we evaluated prototype (D614) and Beta (B.1.351) variant recombinant spike protein …
we evaluated prototype (D614) and Beta (B.1.351) variant recombinant spike protein …
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study
…, JJ Kee, S Kaali, M Koutsoukos, R Masotti… - …, 2023 - thelancet.com
Background The literature on first generation COVID-19 vaccines show they were less effective
against new SARS-CoV-2 variants of concern including Omicron (BA.1, BA.2, BA.4 and …
against new SARS-CoV-2 variants of concern including Omicron (BA.1, BA.2, BA.4 and …
Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind …
…, H Kibuuka, M Koutsoukos, R Masotti… - The Lancet …, 2023 - thelancet.com
Background COVID-19 vaccines with alternative strain compositions are needed to provide
broad protection against newly emergent SARS-CoV-2 variants of concern. This study aimed …
broad protection against newly emergent SARS-CoV-2 variants of concern. This study aimed …
[HTML][HTML] Efficacy of a bivalent (D614+ B. 1.351) SARS-CoV-2 protein vaccine
…, JJ Kee, H Kibuuka, M Koutsoukos, R Masotti… - medRxiv, 2023 - ncbi.nlm.nih.gov
… Pimentel from the Instituto Nacional de Pediatría, México; Victor Mudhune Otieno, Grace
Mugure Mboya, Zipporah Nyamoita Buko, and Taraz Samandari from the KEMRI CGHR …
Mugure Mboya, Zipporah Nyamoita Buko, and Taraz Samandari from the KEMRI CGHR …
Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose …
…, M Koutsoukos, D Lopez, R Masotti… - medRxiv, 2021 - medrxiv.org
Background This study evaluated the safety and immunogenicity of an AS03-adjuvanted
SARS-CoV-2 recombinant protein candidate vaccine, CoV2 preS dTM. Methods This Phase 2, …
SARS-CoV-2 recombinant protein candidate vaccine, CoV2 preS dTM. Methods This Phase 2, …
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: a randomised, placebo-controlled, dose-ranging study
…, MC Keefer, M Koutsoukos, MA Kimmel, R Masotti… - medRxiv, 2021 - medrxiv.org
Background Effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
are urgently needed. CoV2 preS dTM is a stabilised pre-fusion S protein …
are urgently needed. CoV2 preS dTM is a stabilised pre-fusion S protein …
Healthy naturally occurring retirement communities: A low-cost approach to facilitating healthy aging
PJ Masotti, R Fick… - American Journal of …, 2006 - ajph.aphapublications.org
… Johnson-Masotti edited and restructured significant sections the article. S. MacLeod served
as a … Ronald Masotti and Jennifer Ranford for their contributions and suggestions to earlier …
as a … Ronald Masotti and Jennifer Ranford for their contributions and suggestions to earlier …
Large-scale shifts in phytoplankton groups in the Equatorial Pacific during ENSO cycles
I Masotti, C Moulin, S Alvain, L Bopp… - …, 2011 - bg.copernicus.org
The El Niño Southern Oscillation (ENSO) drives important changes in the marine productivity
of the Equatorial Pacific, in particular during major El Niño/La Niña transitions. Changes in …
of the Equatorial Pacific, in particular during major El Niño/La Niña transitions. Changes in …
